Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants?

Park SH, Wackernah RC, Stimmel GL.

J Pharm Pract. 2014 Feb;27(1):71-8. doi: 10.1177/0897190013504957. Review.

PMID:
24153222
2.

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.

Spina E, Santoro V, D'Arrigo C.

Clin Ther. 2008 Jul;30(7):1206-27. Review.

PMID:
18691982
3.

Serotonin Syndrome: Analysis of Cases Registered in the French Pharmacovigilance Database.

Abadie D, Rousseau V, Logerot S, Cottin J, Montastruc JL, Montastruc F.

J Clin Psychopharmacol. 2015 Aug;35(4):382-8. doi: 10.1097/JCP.0000000000000344.

PMID:
26082973
4.

Avoiding serotonin syndrome: the nature of the interaction between tramadol and selective serotonin reuptake inhibitors.

Nelson EM, Philbrick AM.

Ann Pharmacother. 2012 Dec;46(12):1712-6. doi: 10.1345/aph.1Q748. Review.

PMID:
23212934
5.
6.
7.

Clinically significant drug interactions with antidepressants in the elderly.

Spina E, Scordo MG.

Drugs Aging. 2002;19(4):299-320. Review.

PMID:
12038880
8.

Clinically significant drug interactions with newer antidepressants.

Spina E, Trifirò G, Caraci F.

CNS Drugs. 2012 Jan 1;26(1):39-67. doi: 10.2165/11594710-000000000-00000. Review.

PMID:
22171584
9.

Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.

Baumann P.

Clin Pharmacokinet. 1996 Dec;31(6):444-69. Review.

PMID:
8968657
10.

Antidepressant-Induced Hyponatremia in Older Adults.

Viramontes TS, Truong H, Linnebur SA.

Consult Pharm. 2016 Mar;31(3):139-50. doi: 10.4140/TCP.n.2016.139. Review.

PMID:
26975593
11.

[Interactions between metoprolol and antidepressants].

Molden E, Spigset O.

Tidsskr Nor Laegeforen. 2011 Sep 20;131(18):1777-9. doi: 10.4045/tidsskr.11.0143. Review. Norwegian.

12.
13.

Serotonin syndrome after the use of tramadol and ziprasidone in a patient with a deep brain stimulator for Parkinson disease.

El-Okdi NS, Lumbrezer D, Karanovic D, Ghose A, Assaly R.

Am J Ther. 2014 Jul-Aug;21(4):e97-9. doi: 10.1097/MJT.0b013e3182456d88.

PMID:
24158007
14.

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.

Sproule BA, Naranjo CA, Brenmer KE, Hassan PC.

Clin Pharmacokinet. 1997 Dec;33(6):454-71. Review.

PMID:
9435993
15.

Pharmacokinetic optimisation of therapy with newer antidepressants.

Goodnick PJ.

Clin Pharmacokinet. 1994 Oct;27(4):307-30. Review.

PMID:
7834966
16.

Interaction of serotonergic antidepressants and opioid analgesics: Is serotonin syndrome going undetected?

Gnanadesigan N, Espinoza RT, Smith R, Israel M, Reuben DB.

J Am Med Dir Assoc. 2005 Jul-Aug;6(4):265-9.

PMID:
16005413
17.

[Clinically relevant drug interactions with new generation antidepressants and antipsychotics].

Eckert A.

Ther Umsch. 2009 Jun;66(6):485-92. doi: 10.1024/0040-5930.66.6.485. Review. German.

PMID:
19496045
18.

Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.

Thomas SJ, Shin M, McInnis MG, Bostwick JR.

Pharmacotherapy. 2015 Apr;35(4):433-49. doi: 10.1002/phar.1576. Review.

19.

Possible serotonin syndrome associated with tramadol and sertraline coadministration.

Mason BJ, Blackburn KH.

Ann Pharmacother. 1997 Feb;31(2):175-7.

PMID:
9034418
20.

Differential pharmacology of newer antidepressants.

DeVane CL.

J Clin Psychiatry. 1998;59 Suppl 20:85-93. Review.

Supplemental Content

Support Center